Elevation Wealth Partners’s Revolution Medicines RVMD Stock Holding History

Elevation Wealth Partners’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.81K	Buy	+15	New	+$2.19K	﹤0.01%	1143

Other funds holding RVMD

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

FAF

Fjarde Ap-fonden Stockholm, Sweden $20.9B AUM 36.93% 1-Year Est. Return

APM

a16z Perennial Management Menlo Park, California $1.24B AUM 7.36% 1-Year Est. Return

RAM

Resona Asset Management Koto-Ku,tokyo, Japan $21.3B AUM 36.92% 1-Year Est. Return

Elevation Wealth Partners's RVMD Position: Q2 2026 in Review

Elevation Wealth Partners opened a new position in Revolution Medicines (RVMD) in Q2 2026: 15 shares worth $2.81K. The stake represents ﹤0.01% of the portfolio and ranks #1143 among its holdings.

160 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

Elevation Wealth Partners held 15 shares of Revolution Medicines worth $2.81K as of Q2 2026.
Revolution Medicines was a new Elevation Wealth Partners position in Q2 2026.
Revolution Medicines made up ﹤0.01% of Elevation Wealth Partners's portfolio in Q2 2026, its #1143 holding.
160 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Elevation Wealth Partners's 13F filing for Q2 2026, filed 8 Jul 2026.